Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Emma's Children Hospital, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
Support Care Cancer. 2023 Jul 15;31(8):467. doi: 10.1007/s00520-023-07913-1.
Few governments in low and middle-income countries (LMIC) have responded favourably to the international plea for Universal Health Coverage. Childhood cancer survival in LMIC is often below 20%. Limited health-insurance coverage may contribute to this poor survival. Our study explores the influence of health-insurance status on childhood cancer treatment outcomes in a Kenyan academic hospital.
This was a retrospective medical records review of all children diagnosed with cancer at Moi Teaching and Referral Hospital between 2010 and 2016. Socio-demographic and clinical data was collected using a structured data collection form. Fisher's exact test, chi-squared test, Kaplan-Meier method, log-rank test and Cox proportional hazard model were used to evaluate relationships between treatment outcomes and patient characteristics. Study was approved by Institutional Research Ethics Committee.
From 2010-2016, 879 children were newly diagnosed with cancer. Among 763 patients whose records were available, 28% abandoned treatment, 23% died and 17% had progressive/relapsed disease resulting in 32% event-free survival. In total 280 patients (37%) had health-insurance at diagnosis. After active enrolment during treatment, total health-insurance registration level reached 579 patients (76%). Treatment outcomes differed by health-insurance status (P < 0.001). The most likely treatment outcome in uninsured patients was death (49%), whereas in those with health-insurance at diagnosis and those who enrolled during treatment it was event-free survival (36% and 41% respectively). Overall survival (P < 0.001) and event-free survival (P < 0.001) were higher for insured versus uninsured patients. The hazard-ratio for treatment failure was 0.30 (95% CI:0.22-0.39; P < 0.001) for patients insured at diagnosis and 0.32 (95% CI:0.24-0.41; P < 0.001) for patients insured during treatment in relation to those without insurance.
Our study highlights the need for Universal Health Coverage in LMIC. Children without health-insurance had significantly lower survival. Childhood cancer treatment outcomes can be ameliorated by strategies that improve health-insurance access.
在中低收入国家(LMIC),很少有政府对普及医疗保险的国际呼吁做出积极回应。在 LMIC,儿童癌症的存活率通常低于 20%。有限的医疗保险覆盖可能导致这种低存活率。我们的研究探讨了肯尼亚一家学术医院的医疗保险状况对儿童癌症治疗结果的影响。
这是一项对 2010 年至 2016 年间在莫伊教学和转诊医院诊断患有癌症的所有儿童进行的回顾性病历审查。使用结构化数据收集表收集社会人口统计学和临床数据。Fisher 确切检验、卡方检验、Kaplan-Meier 方法、对数秩检验和 Cox 比例风险模型用于评估治疗结果与患者特征之间的关系。本研究获得了机构研究伦理委员会的批准。
2010 年至 2016 年间,有 879 名儿童被新诊断患有癌症。在 763 名可获得记录的患者中,28%的患者放弃了治疗,23%的患者死亡,17%的患者出现进展/复发疾病,导致 32%的无事件生存率。总共有 280 名患者(37%)在诊断时拥有医疗保险。在治疗期间积极登记后,总医疗保险登记率达到 579 名患者(76%)。治疗结果因医疗保险状况而异(P<0.001)。未参保患者最有可能的治疗结果是死亡(49%),而参保患者和治疗期间参保患者的无事件生存率分别为 36%和 41%。总体生存率(P<0.001)和无事件生存率(P<0.001)均高于未参保患者。诊断时参保的患者治疗失败的风险比为 0.30(95%CI:0.22-0.39;P<0.001),治疗期间参保的患者风险比为 0.32(95%CI:0.24-0.41;P<0.001),与未参保患者相比。
我们的研究强调了在 LMIC 实施全民医疗保险的必要性。没有医疗保险的儿童生存率显著降低。通过改善医疗保险获取途径的策略,可以改善儿童癌症的治疗结果。